Block Three January 2023 - February 2023
How Do We Identify Youth With Substance Disorders and Use Available Laboratory Tools to Manage Substance Misuse in Teens?
Objectives:
- Understand the limitations of Urine Drug Screens (UDS)
- Understand the role of UDS in Adolescent SUD
- Describe presentations that may be influenced by substances
- Understand role of specific substances in distinct presentations (cannabis/sub acute bacterial endocarditis (SBE)/recurrent sexual transmitted infections (STI)
1. Asynchronous Content
to be completed before live session on February 16, 2023 .
Urine Drug Testing in Adolescents
Resources for Providers:
- Drug-Testing-Talk-Slides.pdf
- Caring for Patients During the Covid-19 Pandemic: Adjusting Drug Testing Protocols
- Adolescent Drug Testing Policies in Schools
- Public Policy Statement On Drug Testing as a Component of Addiction Treatment and Monitoring Programs and in other Clinical Settings
- Toxicology Screening
2. Next Steps/Lesson Review
This section provides some ideas for consideration to help you think about implementation of the material in your own practice.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. An 80% pass rate is required for eligibility of MOC credit.
3. Live Webinar
February 16, 2023,
12:00 PM
Substance Use Presenting as or Exacerbating Physical or Mental Illness
Resources for Providers:
- POWERPOINT SLIDES - Substance Use Presenting as or Exacerbating Physical or Mental Illness
- 5 Co-Occurring Medical and Psychiatric Conditions
- Evaluation and Management of Children and Adolescents With Acute Mental Health or Behavioral Problems. Part I: Common Clinical Challenges of Patients with Mental Health and/or Behavioral Emergencies
- Dual Diagnosis: Serious Mental Illness and Co-Occurring Substance Use Disorders